<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02924597</url>
  </required_header>
  <id_info>
    <org_study_id>RenJiH-20160829</org_study_id>
    <nct_id>NCT02924597</nct_id>
  </id_info>
  <brief_title>Robot-Assisted Laparoscopic Radio Frequency Ablation Assisted Enucleation of Renal Cell Carcinoma With T1a Stage</brief_title>
  <official_title>Robot-Assisted Laparoscopic Radio Frequency Ablation Assisted Enucleation of Renal Cell Carcinoma With T1a Stage : Clinical Outcomes of a Randomised Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RenJi Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>RenJi Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the feasibility and efﬁciency of zero ischemia robot-assisted laparoscopic radio
      frequency ablation assisted enucleation of T1a renal cell carcinoma in comparison with
      robot-assisted laparoscopic partial nephrectomy without hilar clamping.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Anticipated">August 2018</completion_date>
  <primary_completion_date type="Anticipated">August 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The absolute change in glomerular ﬁltration rate (GFR) of the aﬀected kidney</measure>
    <time_frame>baseline and 12 months</time_frame>
    <description>12 months minus baseline</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The changes of estimated GFR (eGFR)</measure>
    <time_frame>baseline and 12 months</time_frame>
    <description>12 months minus baseline</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>estimated blood loss</measure>
    <time_frame>during surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>changes in GFR of total kidneys by renal scintigraphyby</measure>
    <time_frame>baseline and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>surgical margin</measure>
    <time_frame>postoperative，up to 2 weeks after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative complications</measure>
    <time_frame>postoperative，up to 30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>progression-free survival</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>local recurrence</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>operative time</measure>
    <time_frame>During surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital stay time</measure>
    <time_frame>The time from the surgery day to patient discharge, up to 2 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>changes in GFR of total kidneys by renal scintigraphyby of 6 month</measure>
    <time_frame>baseline and 6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Renal Cell Carcinoma</condition>
  <arm_group>
    <arm_group_label>Robot-assisted laparoscopic RFA assisted TE</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>RFA will be performed for 1 to 4 cycles for 4 to 12 minutes each depending on tumor size and depth. The tumor then will be laparoscopic enucleation without hilar clamping.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Robot-Assisted laparoscopic partial nephrectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The tumor then will be laparoscopic enucleation without hilar clamping.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>zero ischemia robot-assisted laparoscopic RFA assisted TE</intervention_name>
    <arm_group_label>Robot-assisted laparoscopic RFA assisted TE</arm_group_label>
    <other_name>zero ischemia robot-assisted laparoscopic radio frequency ablation assisted tumor enucleation</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>zero ischemia robot-assisted laparoscopic partial nephrectomy</intervention_name>
    <arm_group_label>Robot-Assisted laparoscopic partial nephrectomy</arm_group_label>
    <other_name>Off-clamp robot-assisted partial nephrectomy</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with sporadic, unilateral, newly diagnosed T1a presumed renal cell carcinoma

          -  patients scheduled for robot-assisted laparoscopic nephron sparing surgery

          -  patients with normal contralateral renal function (diﬀerential renal function of &gt;40%
             as determined by radionuclide scintigraphy)

          -  patients agreeable to participate in this long-term follow-up study

        Exclusion Criteria:

          -  patients' aged &gt;80 years

          -  patients with other renal diseases,(including kidney stone, glomerular nephritis,
             etc.) which might affect the renal function of the operative kidney

          -  patients not able to tolerate the robot-assisted laparoscopic procedure

          -  patients with previous renal surgery or history of any inﬂammatory conditions of the
             operative kidney

          -  patients with the renal tumor involving urinary collecting system
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jin Zhang, PhD.</last_name>
    <phone>+8618801967501</phone>
    <email>rjxuyunze@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yiran Huang, MD.</last_name>
    <phone>+8613501835219</phone>
    <email>huangyrrenji@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ethics Committee of Shanghai Renji Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Qi Lu</last_name>
      <phone>+86021-68383364</phone>
      <email>rjllb3364@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 3, 2016</study_first_submitted>
  <study_first_submitted_qc>October 3, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 5, 2016</study_first_posted>
  <last_update_submitted>October 3, 2016</last_update_submitted>
  <last_update_submitted_qc>October 3, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 5, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Carcinoma, Renal Cell</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

